Your browser doesn't support javascript.
loading
Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences.
Sinh, Preetika; Cross, Raymond K.
  • Sinh P; Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Cross RK; Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, Maryland.
Gastroenterol Hepatol (N Y) ; 20(4): 204-215, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38682122
ABSTRACT
Patients with inflammatory bowel disease (IBD) have an increased risk of cardiovascular disease (CVD) such as myocardial infarction and stroke. CVD in patients with IBD might occur in those with younger age and active disease, which are not traditional risk factors of CVD. Atherosclerotic CVD (ASCVD) and IBD are both proinflammatory conditions, and the underlying chronic inflammation might drive ASCVD risk. Decreasing inflammation might reduce this risk; however, data are limited. IBD medications can increase or decrease ASCVD risk. There are no specific guidelines or modalities to assess ASCVD in IBD. Early detection and risk stratification strategies have been established in other chronic inflammatory disorders. This article discusses causes of CVD in IBD and strategies to modify the consequences.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article